Cargando…

Hepatitis C virus elimination: time for disruptive innovation

Detalles Bibliográficos
Autor principal: Klein, Marina B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658838/
https://www.ncbi.nlm.nih.gov/pubmed/31347280
http://dx.doi.org/10.1002/jia2.25360
_version_ 1783439024734601216
author Klein, Marina B
author_facet Klein, Marina B
author_sort Klein, Marina B
collection PubMed
description
format Online
Article
Text
id pubmed-6658838
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66588382019-08-01 Hepatitis C virus elimination: time for disruptive innovation Klein, Marina B J Int AIDS Soc Viewpoints John Wiley and Sons Inc. 2019-07-26 /pmc/articles/PMC6658838/ /pubmed/31347280 http://dx.doi.org/10.1002/jia2.25360 Text en © 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Viewpoints
Klein, Marina B
Hepatitis C virus elimination: time for disruptive innovation
title Hepatitis C virus elimination: time for disruptive innovation
title_full Hepatitis C virus elimination: time for disruptive innovation
title_fullStr Hepatitis C virus elimination: time for disruptive innovation
title_full_unstemmed Hepatitis C virus elimination: time for disruptive innovation
title_short Hepatitis C virus elimination: time for disruptive innovation
title_sort hepatitis c virus elimination: time for disruptive innovation
topic Viewpoints
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658838/
https://www.ncbi.nlm.nih.gov/pubmed/31347280
http://dx.doi.org/10.1002/jia2.25360
work_keys_str_mv AT kleinmarinab hepatitiscviruseliminationtimefordisruptiveinnovation